Free Trial

Mineralys Therapeutics (MLYS) SEC Filings & 10K Form

Mineralys Therapeutics logo
$13.78 +0.08 (+0.58%)
As of 09:58 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Mineralys Therapeutics SEC Filings

DateFilerForm TypeView
06/17/2025
6:07 AM
Mineralys Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2025
3:23 PM
Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2025
6:01 PM
Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
7:57 PM
Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2025
4:31 PM
Mineralys Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2025
6:01 PM
Catalys Pacific Fund, LP (Reporting)
Mineralys Therapeutics (Issuer)
Slingsby Brian Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2025
3:11 PM
Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/09/2025
7:16 AM
Mineralys Therapeutics (Filer)
Form DEF 14A
04/09/2025
7:18 AM
Mineralys Therapeutics (Filer)
Form DEFA14A
04/09/2025
7:21 AM
Mineralys Therapeutics (Filer)
Form ARS
04/03/2025
4:36 PM
Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
3:44 PM
Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/31/2025
7:15 AM
Mineralys Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2025
8:04 PM
AKKARAJU SRINIVAS (Reporting)
Mineralys Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
8:05 PM
Mineralys Therapeutics (Issuer)
Samsara BioCapital GP, LLC (Reporting)
Samsara BioCapital, L.P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
8:06 PM
Mineralys Therapeutics (Subject)
Samsara BioCapital, L.P. (Filed by)
Form SCHEDULE 13D/A
03/17/2025
6:56 PM
Kolchinsky Peter (Reporting)
Mineralys Therapeutics (Issuer)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
6:58 PM
Mineralys Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SCHEDULE 13D/A
03/13/2025
4:15 PM
Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
6:05 AM
Mineralys Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2025
8:41 PM
Kolchinsky Peter (Reporting)
Mineralys Therapeutics (Issuer)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
5:58 PM
Mineralys Therapeutics (Issuer)
SBLENDORIO GLENN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
5:58 PM
Karydas Daphne (Reporting)
Mineralys Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
5:58 PM
Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
5:59 PM
Gold Alexander M (Reporting)
Mineralys Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
5:59 PM
DiRocco Derek (Reporting)
Mineralys Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
5:59 PM
Catalys Pacific Fund, LP (Reporting)
Mineralys Therapeutics (Issuer)
Slingsby Brian Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
5:59 PM
AKKARAJU SRINIVAS (Reporting)
Mineralys Therapeutics (Issuer)
Samsara BioCapital, L.P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
5:59 PM
Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
5:59 PM
Levy Adam Scott (Reporting)
Mineralys Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:03 AM
Mineralys Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/14/2025
5:03 AM
ADAMS STREET PARTNERS LLC (Filed by)
Mineralys Therapeutics (Subject)
Form SCHEDULE 13G/A
02/13/2025
4:29 PM
Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
6:07 AM
Mineralys Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
7:05 AM
Mineralys Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2025
8:44 PM
Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
8:45 PM
Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
8:46 PM
Levy Adam Scott (Reporting)
Mineralys Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
5:21 PM
Levy Adam Scott (Reporting)
Mineralys Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
5:34 PM
Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
7:07 AM
Mineralys Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)

Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.

For the moment, you can watch this interview free of charge – just click here.
01/07/2025
4:58 PM
Catalys Pacific Fund, LP (Reporting)
Mineralys Therapeutics (Issuer)
Slingsby Brian Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
3:37 PM
Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
9:40 AM
Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
5:43 PM
Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/30/2024
7:03 AM
Mineralys Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
3:21 PM
Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
3:22 PM
Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
3:22 PM
Levy Adam Scott (Reporting)
Mineralys Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2024
3:48 PM
Levy Adam Scott (Reporting)
Mineralys Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/11/2024
3:54 PM
Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/25/2024
7:06 AM
Mineralys Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
3:32 PM
Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:20 PM
Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
8:45 PM
Catalys Pacific Fund, LP (Reporting)
Mineralys Therapeutics (Issuer)
Slingsby Brian Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
3:50 PM
Catalys Pacific Fund, LP (Reporting)
Mineralys Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/18/2024
5:34 PM
Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
3:41 PM
Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/12/2024
3:36 PM
Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
3:37 PM
Levy Adam Scott (Reporting)
Mineralys Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
3:39 PM
Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
3:51 PM
Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/11/2024
3:53 PM
Levy Adam Scott (Reporting)
Mineralys Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MLYS) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners